Deucravacitinib | High-Quality Pharmaceutical Reference Standard
Deucravacitinib API is a selective TYK2 (tyrosine kinase 2) inhibitor indicated for the treatment of moderate to severe plaque psoriasis. It is formulated for oral solid dosage forms.
Deucravacitinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6
